http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015058080-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42dd2fda915a24e6908bba97316b0621
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61H2033-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-054
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-16
filingDate 2014-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33fabc50a114b575161342ccee74f458
publicationDate 2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015058080-A1
titleOfInvention System and method for transdermal dialysis
abstract A system/method is provided for treatment of end stage renal disease ("ESRD") using transdermal dialysis ("TDD"), such as to treat both acute and chronic ESRD. Generally, a patient's epidermal surface may be used as a dialysis membrane in the treatment of ESRD. A patient suffering from ESRD using TDD may be treated, where the patient's epidermal membrane ("EM") surface serves as the dialysis membrane. In such a system or method, the patient's EM may be contacted with a dialysate solution to thereby allow wastes and toxins to pass from beneath the patient's EM, through the patient's EM and into the dialysate solution. In a particular embodiment, the patient's EM is exposed to a prescribed electric field, to thereby increase the permeability of the patient's EM.
priorityDate 2013-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8803821-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011105871-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5032109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5911223-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011111029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008015494-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID588

Total number of triples: 26.